Cargando…

Splenic-targeting biomimetic nanovaccine for elevating protective immunity against virus infection

BACKGROUND: The prevalence of viral infectious diseases has become a serious threat to public safety, economic and social development. Vaccines have been served as the most effective platform to prevent virus transmission via the activation of host immune responses, while the low immunogenicity or s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Jian, Zhang, Angke, Wang, Shuqi, Cheng, Hanghang, Fan, Daopeng, Huang, Ran, Wang, Yanan, Wan, Bo, Zhang, Gaiping, He, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719655/ https://www.ncbi.nlm.nih.gov/pubmed/36463277 http://dx.doi.org/10.1186/s12951-022-01730-0

Ejemplares similares

Multi-Site Attack, Neutrophil Membrane-Camouflaged Nanomedicine with High Drug Loading for Enhanced Cancer Therapy and Metastasis Inhibition
por: Huang, Ran, et al.
Publicado: (2023)

Nanovaccine Confers Dual Protection Against Influenza A Virus And Porcine Circovirus Type 2
por: Ding, Peiyang, et al.
Publicado: (2019)

Scalable biomimetic SARS-CoV‑2 nanovaccines with robust protective immune responses
por: Chen, Xuenian, et al.
Publicado: (2022)

Recent Advances in Nanovaccines Using Biomimetic Immunomodulatory Materials
por: Vijayan, Veena, et al.
Publicado: (2019)

Light-Assisted “Nano-Neutrophils” with High Drug Loading for Targeted Cancer Therapy
por: Fan, Daopeng, et al.
Publicado: (2023)

A Versatile and Robust Platform for the Scalable Manufacture of Biomimetic Nanovaccines
por: Hu, Hanze, et al.
Publicado: (2021)

A biomimetic antitumor nanovaccine based on biocompatible calcium pyrophosphate and tumor cell membrane antigens
por: Li, Minghui, et al.
Publicado: (2021)

Inhalable nanovaccine with biomimetic coronavirus structure to trigger mucosal immunity of respiratory tract against COVID-19
por: Zheng, Bin, et al.
Publicado: (2021)

The Cytoprotective Enzyme Heme Oxygenase-1 Suppresses Pseudorabies Virus Replication in vitro
por: Zhang, Angke, et al.
Publicado: (2020)

Protective RNA nanovaccines against Mycobacterium avium subspecies hominissuis
por: Touray, Bubacarr J.B., et al.
Publicado: (2023)

Biomimetic nanovaccine-mediated multivalent IL-15 self-transpresentation (MIST) for potent and safe cancer immunotherapy
por: Wang, Kaiyuan, et al.
Publicado: (2023)

Self-Assembling Nanovaccine Enhances Protective Efficacy Against CSFV in Pigs
por: Liu, Ze-Hui, et al.
Publicado: (2021)

RNA Nanovaccine Protects against White Spot Syndrome Virus in Shrimp
por: Phanse, Yashdeep, et al.
Publicado: (2022)

A splenic-targeted versatile antigen courier: iPSC wrapped in coalescent erythrocyte-liposome as tumor nanovaccine
por: Zhai, Yuewen, et al.
Publicado: (2021)

Nanovaccines against Viral Infectious Diseases
por: Heng, Wen Tzuen, et al.
Publicado: (2022)

Chitosan Nanovaccines as Efficient Carrier Adjuvant System for IL-12 with Enhanced Protection Against HBV
por: Zhao, Huajun, et al.
Publicado: (2021)

Self-Assembling Nanovaccine Confers Complete Protection Against Zika Virus Without Causing Antibody-Dependent Enhancement
por: Rong, Heng, et al.
Publicado: (2022)

Nanovaccines against Animal Pathogens: The Latest Findings
por: Celis-Giraldo, Carmen Teresa, et al.
Publicado: (2021)

Virosome-based nanovaccines; a promising bioinspiration and biomimetic approach for preventing viral diseases: A review
por: Asadi, Khatereh, et al.
Publicado: (2021)

Establishment of a Dual-Antigen Indirect ELISA Based on p30 and pB602L to Detect Antibodies against African Swine Fever Virus
por: Zhou, Lei, et al.
Publicado: (2023)

Self-Assembly M2e-Based Peptide Nanovaccine Confers Broad Protection Against Influenza Viruses
por: Wang, Qimin, et al.
Publicado: (2020)

Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus
por: Wang, Yaling, et al.
Publicado: (2021)

Pulmonary delivery of mucosal nanovaccines
por: Tang, Wei, et al.
Publicado: (2021)

Bacterial extracellular vesicle-coated multi-antigenic nanovaccines protect against drug-resistant Staphylococcus aureus infection by modulating antigen processing and presentation pathways
por: Chen, Gang, et al.
Publicado: (2020)

Immersion Vaccination by a Biomimetic-Mucoadhesive Nanovaccine Induces Humoral Immune Response of Red Tilapia (Oreochromis sp.) against Flavobacterium columnare Challenge
por: Kitiyodom, Sirikorn, et al.
Publicado: (2021)

Self−Assembling Nanovaccine Fused with Flagellin Enhances Protective Effect against Foot−and−Mouth Disease Virus
por: Pei, Chenchen, et al.
Publicado: (2023)

Protein nanovaccine confers robust immunity against Toxoplasma
por: El Bissati, Kamal, et al.
Publicado: (2017)

TAT Nanobody Exerts Antiviral Effect against PRRSV In Vitro by Targeting Viral Nucleocapsid Protein
por: Ren, Jiahui, et al.
Publicado: (2023)

In Situ Cocktail Nanovaccine for Cancer Immunotherapy
por: Liu, Mohan, et al.
Publicado: (2023)

Xyloglucan based mucosal nanovaccine for immunological protection against brucellosis developed by supercritical fluid technology
por: Vyas, Swati, et al.
Publicado: (2020)

Development of a Directly Visualized Recombinase Polymerase Amplification–SYBR Green I Method for the Rapid Detection of African Swine Fever Virus
por: Zhang, Shuai, et al.
Publicado: (2020)

HRP-conjugated-nanobody-based cELISA for rapid and sensitive clinical detection of ASFV antibodies
por: Zhao, Huijun, et al.
Publicado: (2022)

A STING-Activating Nanovaccine for Cancer Immunotherapy
por: Luo, Min, et al.
Publicado: (2017)

P22-Based Nanovaccines against Enterohemorrhagic Escherichia coli
por: Huerta-Saquero, Alejandro, et al.
Publicado: (2023)

A chitosan-mediated inhalable nanovaccine against SARS-CoV-2
por: Zhuo, Shao-Hua, et al.
Publicado: (2022)

MicroRNA-like viral small RNA from porcine reproductive and respiratory syndrome virus negatively regulates viral replication by targeting the viral nonstructural protein 2
por: Li, Na, et al.
Publicado: (2016)

Advancements in prophylactic and therapeutic nanovaccines
por: Bhardwaj, Prateek, et al.
Publicado: (2020)

Self-adjuvanting cancer nanovaccines
por: Liao, Zhiyun, et al.
Publicado: (2022)

Addressing Nanovaccine Strategies for Tilapia
por: Thompson, Kim D., et al.
Publicado: (2023)

Semisynthetic Pneumococcal Glycoconjugate Nanovaccine
por: Prasanna, Maruthi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o0fpah44ljl4j4o4jsqjn0rl5s